Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)

Respiratory Syncytial Virus infections are one of the leading causes of severe respiratory diseases that require hospitalization and, in some cases, intensive care. Once resolved, there may be respiratory sequelae of varying severity. The lack of effective treatments for bronchiolitis and the lack o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ital J Pediatr
Main Authors: Bollani, Lina, Baraldi, Eugenio, Chirico, Gaetano, Dotta, Andrea, Lanari, Marcello, Del Vecchio, Antonello, Manzoni, Paolo, Boldrini, Antonio, Paolillo, Piermichele, Di Fabio, Sandra, Orfeo, Luigi, Stronati, Mauro, Romagnoli, Costantino
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4681171/
https://ncbi.nlm.nih.gov/pubmed/26670908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13052-015-0203-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados